AIM movers: Improved feed grades for Rockfire Resources and Iofina production lower than expected
Eden BioSolutions (LON: EDEN) has been granted an unconditional registration by the US authorities for Mevalone Delta, an optimised biofungicide formulation based upon Eden’s registered active ingredients and microencapsulation technology, Sustaine®. The addressable market in the US is estimated to be $114m. The share price gained 21% to 3.75p.
Ore sorting tests by Rockfire Resources (LON: ROCK) show improvement in the feed upgrade at the Molaoi zinc deposit in Greece. The initial feed grade was 5.85% zinc, and this increased to 13.6% zinc. Even after removing high-density ore, the grade was 11.7% zinc. Even with the lowest grade ore the figure was 9.9% and there was 97.7% recovery of zinc. The maiden JORC germanium resource should be announced soon. The share price increased 5.45% to 0.145p.
– Advertisement –
Iodine producer Iofina (LON: IOF) has commissioned its IO#12 plant in the Permian Basin and production should begin in a few weeks. In the third quarter 205.2Mt of crystalline iodine, down from 215.8Mt one year earlier due to lower water volumes and maintenance. Also, IO#12 was expected to be in production before the end of the quarter. Second half production is expected to be 440Mt to 445Mt, depending on water supply, down from previous guidance of 460-485Mt. First half production was 393.3Mt. The iodine price remains strong. The share price improved 4.175 to 50p.
FALLERS
Caspian Sunrise (LON: CASP) announced that its AGM will be held on 8 December. On Thursday, the shares returned from suspension having published the 2005 accounts and this year’s interim figures. Revenues dived to $100,000 in the first half of 2026. The loss increased from $1.8m to $3.8m. Cash was $11.9m at the end of June 2026. The first oil was produced from the West Shalva contract area during the period. Since then, oil production from Well P2 at the Sholkara structure on the Block 8 Contract Area has been at the rate of 90 barrels of oil per day. The share price dived 31.5% to 0.925p.
Third quarter production at Touchstone Exploration (LON: TXP) was 1% higher in the third quarter than the previous quarter. However, the 4,485 boe/day average was 13% lower than one year before. Oil and gas sales were 30% higher than one year earlier at $16.5m due to higher prices. Net debt was $57.3m at the end of September 2026. Production increased in October. The share price declined 7.69% to 9p.
Allergy Therapeutics (LON: AGY) increased full year revenues 9% to £59.9m, while second half growth was 12%. This year will benefit from a high season of Grassmuno availability. Allergy Therapeutics intends to leave AIM. The share price slipped 2.68% to 1.45p.
National Wealth Fund increased its stake in Invinity Energy Systems (LON: IES) from 24.7% to 28.1%. There was a reduction in the NextGen Mobility shareholding from 11.3% to 7.83%. This follows the £25m raised by the vanadium flow battery technology developer at 10p/share. The share price dipped 1.96% to 10p.
